When we drink little, we produce less urine. But how is this process regulated? An international team of scientists led by Prof. Kai Schmidt-Ott of the Max Delbrück Center for Molecular Medicine (MDC) ...

The discovery of how certain key structures in the kidneys are formed could have important implications for treating renal fibrosis (or scarring), a feature of chronic kidney disease (CKD), according ...

The controversies which, in the past, have A characterized the experimental literature on the nature of renal function have resulted in large part from lack of information concerning the composition ...

In recent decades, the emphasis of biomarker research has centered around blood-based markers. However, blood biomarkers alone cannot capture the full spectrum of clinically relevant indicators.

Tolvaptan, an arginine vasopressin receptor antagonist, decreases urinary supersaturation in kidney stone formers by considerably increasing diuresis, suggesting that this drug might be an effective ...